3,4-methylenedioxyamphetamine has been researched along with Coma in 3 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holden, R | 1 |
Jackson, MA | 1 |
Kaskey, GB | 1 |
Grange, SL | 1 |
Castro, S | 1 |
Owensby, S | 1 |
Thorpe, M | 1 |
3 other studies available for 3,4-methylenedioxyamphetamine and Coma
Article | Year |
---|---|
Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA)
Topics: 3,4-Methylenedioxyamphetamine; Adult; Coma; Hallucinogens; Humans; Hyponatremia; Male; Serotonin Age | 1996 |
Possible interaction between an MAOI and "ecstasy".
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Coma; Delirium; Designer Drugs; Drug Interactions; Female | 1992 |
Keeping the circle of love alive.
Topics: Adaptation, Psychological; Aged; Cerebrovascular Disorders; Coma; Family; Female; Humans; Love; Pati | 1996 |